Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.
about
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical ImplicationsTERT promoter mutations in thyroid cancerThe Role of ATRX in the Alternative Lengthening of Telomeres (ALT) PhenotypeWithaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.RAC3 more than a nuclear receptor coactivator: a key inhibitor of senescence that is downregulated in aging.Conserved Telomere Length in Human Ectopic Thyroids: An Argument Against Premature Differentiation Causing Arrested Migration.Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer.TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.ALTernative Telomere Maintenance and Cancer.The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer.Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT).Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.Telomere Maintenance Mechanisms in Cancer.Cytology and Pathology: Pitfalls and Challenges
P2860
Q26738705-C8275932-C9D0-4015-8AC1-7B0FD640E83BQ26770808-44407D0B-6E4D-4FE7-B346-4B64E403FD6CQ28071562-0E86C20E-C708-41D7-9BB1-99C32C66DAD0Q33815938-3FA8DD3E-F7A5-440E-BC87-BABE8D11446FQ36246392-55C10580-5E6D-46D0-8B82-29A8492BE5E9Q36558335-D57A64A8-0172-40CA-8CE1-F9CD5E6BA3B4Q37225274-878734D4-47C8-495E-B4F6-E571B80BF967Q37580294-5FDB21A9-7249-4910-91A2-6972BA734FF2Q38383121-2D2AD937-ADA5-4941-AFCA-89640A2CAA21Q41844732-E1B5581C-FD1C-4D9B-9A6D-D6067F4BD952Q46805268-D4FA1A79-350D-4879-8C84-F90E27BA7E1EQ49803981-6820DB00-65EB-476D-9033-CD16C31396C2Q52598196-1198D98A-8A22-4A29-B089-68E5E04BA685Q55443450-057F8705-8BA7-4D3C-96DD-D2BD243619E8Q57793652-A16D22D1-A755-4955-AD5A-0A86E9F50FB8
P2860
Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@ast
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@en
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@nl
type
label
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@ast
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@en
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@nl
prefLabel
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@ast
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@en
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@nl
P2093
P2860
P356
P1476
Telomerase-dependent and indep ...... n medullary thyroid carcinoma.
@en
P2093
Anders Höög
Catharina Larsson
Jan Zedenius
Martin Bäckdahl
P2860
P304
P356
10.1210/JC.2014-1158
P407
P577
2014-04-23T00:00:00Z